nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosfomycin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Fosfomycin—Haematuria—Lisinopril—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Fosfomycin—Myalgia—Captopril—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Fosfomycin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Fosfomycin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Fosfomycin—Paraesthesia—Mometasone—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Fosfomycin—Dysuria—Mycophenolate mofetil—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Fosfomycin—Dry mouth—Captopril—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Fosfomycin—Dyspepsia—Mometasone—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Fosfomycin—Anaphylactic shock—Captopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Fosfomycin—Rhinitis—Lisinopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Fosfomycin—Flatulence—Leflunomide—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Fosfomycin—Decreased appetite—Mometasone—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Fosfomycin—Pharyngitis—Lisinopril—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Fosfomycin—Vaginal inflammation—Methotrexate—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Fosfomycin—Back pain—Leflunomide—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Fosfomycin—Pain—Mometasone—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Fosfomycin—Anorexia—Captopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Fosfomycin—Flatulence—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Fosfomycin—Asthenia—Pentoxifylline—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Fosfomycin—Tension—Mycophenolic acid—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Fosfomycin—Nervousness—Mycophenolic acid—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Fosfomycin—Pruritus—Pentoxifylline—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Fosfomycin—Back pain—Mycophenolic acid—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Fosfomycin—Vaginal infection—Methotrexate—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Fosfomycin—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Fosfomycin—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Fosfomycin—Angioedema—Leflunomide—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Fosfomycin—Myalgia—Azathioprine—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Fosfomycin—Insomnia—Captopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Fosfomycin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Fosfomycin—Abdominal pain—Mometasone—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Fosfomycin—Body temperature increased—Mometasone—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Fosfomycin—Paraesthesia—Captopril—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Fosfomycin—Somnolence—Captopril—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Fosfomycin—Dyspepsia—Captopril—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Fosfomycin—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Fosfomycin—Dizziness—Pentoxifylline—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Fosfomycin—Decreased appetite—Captopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Fosfomycin—Infection—Azathioprine—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Fosfomycin—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Fosfomycin—Myalgia—Leflunomide—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Fosfomycin—Constipation—Captopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Fosfomycin—Flatulence—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Fosfomycin—Tension—Lisinopril—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Fosfomycin—Skin disorder—Azathioprine—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Fosfomycin—Nervousness—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Fosfomycin—Dry mouth—Leflunomide—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Fosfomycin—Back pain—Lisinopril—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Fosfomycin—Vomiting—Pentoxifylline—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Fosfomycin—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Fosfomycin—Rash—Pentoxifylline—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Fosfomycin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Fosfomycin—Headache—Pentoxifylline—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Fosfomycin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Fosfomycin—Myalgia—Mycophenolic acid—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Fosfomycin—Infection—Leflunomide—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Captopril—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Fosfomycin—Asthenia—Mometasone—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Fosfomycin—Pruritus—Mometasone—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Fosfomycin—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Fosfomycin—Skin disorder—Leflunomide—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Fosfomycin—Angioedema—Lisinopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Fosfomycin—Abdominal pain—Captopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Fosfomycin—Body temperature increased—Captopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Fosfomycin—Anorexia—Leflunomide—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Fosfomycin—Nausea—Pentoxifylline—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Fosfomycin—Infection—Mycophenolic acid—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Fosfomycin—Diarrhoea—Mometasone—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Fosfomycin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Fosfomycin—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Fosfomycin—Anorexia—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Fosfomycin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Fosfomycin—Tension—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Fosfomycin—Insomnia—Leflunomide—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Fosfomycin—Paraesthesia—Leflunomide—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Fosfomycin—Myalgia—Lisinopril—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Fosfomycin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Fosfomycin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Fosfomycin—Dyspepsia—Leflunomide—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Fosfomycin—Vomiting—Mometasone—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Fosfomycin—Dry mouth—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Fosfomycin—Rash—Mometasone—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Fosfomycin—Asthenia—Captopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Fosfomycin—Dermatitis—Mometasone—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Fosfomycin—Decreased appetite—Leflunomide—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Fosfomycin—Headache—Mometasone—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Fosfomycin—Insomnia—Mycophenolic acid—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Fosfomycin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Fosfomycin—Pruritus—Captopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Fosfomycin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Fosfomycin—Constipation—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Fosfomycin—Pain—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Fosfomycin—Infection—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Fosfomycin—Somnolence—Mycophenolic acid—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Fosfomycin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Fosfomycin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Fosfomycin—Body temperature increased—Azathioprine—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Fosfomycin—Abdominal pain—Azathioprine—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Fosfomycin—Skin disorder—Lisinopril—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Fosfomycin—Diarrhoea—Captopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Fosfomycin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Fosfomycin—Nausea—Mometasone—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Fosfomycin—Anorexia—Lisinopril—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Fosfomycin—Pain—Mycophenolic acid—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Fosfomycin—Constipation—Mycophenolic acid—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Fosfomycin—Dizziness—Captopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Fosfomycin—Abdominal pain—Leflunomide—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Fosfomycin—Body temperature increased—Leflunomide—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Fosfomycin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Fosfomycin—Insomnia—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Fosfomycin—Paraesthesia—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Fosfomycin—Vomiting—Captopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Fosfomycin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Fosfomycin—Rash—Captopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Fosfomycin—Dermatitis—Captopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Fosfomycin—Somnolence—Lisinopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Fosfomycin—Headache—Captopril—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Fosfomycin—Dyspepsia—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Fosfomycin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Fosfomycin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Fosfomycin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Fosfomycin—Asthma—Methotrexate—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Fosfomycin—Infection—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Fosfomycin—Decreased appetite—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Fosfomycin—Eosinophilia—Methotrexate—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Fosfomycin—Constipation—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Fosfomycin—Pain—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Fosfomycin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Fosfomycin—Diarrhoea—Azathioprine—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Fosfomycin—Nausea—Captopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Fosfomycin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Fosfomycin—Asthenia—Leflunomide—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Fosfomycin—Pruritus—Leflunomide—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Fosfomycin—Dysuria—Methotrexate—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Fosfomycin—Dizziness—Azathioprine—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Fosfomycin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Fosfomycin—Diarrhoea—Leflunomide—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Fosfomycin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Fosfomycin—Abdominal pain—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Fosfomycin—Body temperature increased—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Fosfomycin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Fosfomycin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Fosfomycin—Vomiting—Azathioprine—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Fosfomycin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Fosfomycin—Rash—Azathioprine—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Fosfomycin—Dermatitis—Azathioprine—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Fosfomycin—Headache—Azathioprine—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Fosfomycin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Fosfomycin—Dizziness—Leflunomide—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Fosfomycin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Fosfomycin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Fosfomycin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Fosfomycin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Fosfomycin—Haematuria—Methotrexate—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Fosfomycin—Vomiting—Leflunomide—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Fosfomycin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Fosfomycin—Rash—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Fosfomycin—Dermatitis—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Fosfomycin—Nausea—Azathioprine—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Fosfomycin—Headache—Leflunomide—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Fosfomycin—Asthenia—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Fosfomycin—Pruritus—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Fosfomycin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Fosfomycin—Rash—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Fosfomycin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Fosfomycin—Headache—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Fosfomycin—Pharyngitis—Methotrexate—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Fosfomycin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Fosfomycin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Fosfomycin—Nausea—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Fosfomycin—Diarrhoea—Lisinopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Fosfomycin—Angioedema—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Fosfomycin—Dizziness—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Fosfomycin—Nausea—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Fosfomycin—Vomiting—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Fosfomycin—Rash—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Fosfomycin—Dermatitis—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Fosfomycin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Fosfomycin—Headache—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Fosfomycin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Fosfomycin—Myalgia—Prednisone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Fosfomycin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Fosfomycin—Nausea—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Fosfomycin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Fosfomycin—Infection—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Fosfomycin—Back pain—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Fosfomycin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Fosfomycin—Skin disorder—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Fosfomycin—Anorexia—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Fosfomycin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Fosfomycin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Fosfomycin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Fosfomycin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Fosfomycin—Insomnia—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Fosfomycin—Paraesthesia—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Fosfomycin—Dyspepsia—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Fosfomycin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Fosfomycin—Myalgia—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Fosfomycin—Decreased appetite—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Fosfomycin—Constipation—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Fosfomycin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Fosfomycin—Infection—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Fosfomycin—Skin disorder—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Fosfomycin—Anorexia—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Fosfomycin—Body temperature increased—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Fosfomycin—Abdominal pain—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Fosfomycin—Insomnia—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Fosfomycin—Paraesthesia—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Fosfomycin—Somnolence—Methotrexate—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Fosfomycin—Dyspepsia—Methotrexate—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Fosfomycin—Decreased appetite—Methotrexate—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Fosfomycin—Asthenia—Prednisone—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Fosfomycin—Pain—Methotrexate—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Fosfomycin—Pruritus—Prednisone—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Fosfomycin—Diarrhoea—Prednisone—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Fosfomycin—Dizziness—Prednisone—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Fosfomycin—Body temperature increased—Methotrexate—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Fosfomycin—Abdominal pain—Methotrexate—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Fosfomycin—Vomiting—Prednisone—systemic scleroderma	0.000851	0.000851	CcSEcCtD
Fosfomycin—Rash—Prednisone—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Fosfomycin—Dermatitis—Prednisone—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Fosfomycin—Headache—Prednisone—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Fosfomycin—Asthenia—Methotrexate—systemic scleroderma	0.000802	0.000802	CcSEcCtD
Fosfomycin—Nausea—Prednisone—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Fosfomycin—Pruritus—Methotrexate—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Fosfomycin—Diarrhoea—Methotrexate—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Fosfomycin—Dizziness—Methotrexate—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Fosfomycin—Vomiting—Methotrexate—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Fosfomycin—Rash—Methotrexate—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Fosfomycin—Dermatitis—Methotrexate—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Fosfomycin—Headache—Methotrexate—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Fosfomycin—Nausea—Methotrexate—systemic scleroderma	0.000664	0.000664	CcSEcCtD
